Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Equillium (EQ) Return on Sales (2022 - 2025)

Equillium (EQ) has disclosed Return on Sales for 4 consecutive years, with 5.68% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales fell 568.0% to 5.68% in Q3 2025 year-over-year; TTM through Sep 2025 was 5.68%, a 558.0% decrease, with the full-year FY2024 number at 0.2%, up 17.0% from a year prior.
  • Return on Sales was 5.68% for Q3 2025 at Equillium, down from 1.24% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 146.73% in Q1 2022 to a low of 233.12% in Q4 2022.
  • A 4-year average of 0.59% and a median of 0.37% in 2023 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 23287bps in 2023; the steepest drop was -14718bps in 2023.
  • Equillium's Return on Sales stood at 233.12% in 2022, then soared by 100bps to 0.26% in 2023, then tumbled by -414bps to 1.32% in 2024, then crashed by -330bps to 5.68% in 2025.
  • Per Business Quant, the three most recent readings for EQ's Return on Sales are 5.68% (Q3 2025), 1.24% (Q2 2025), and 0.46% (Q1 2025).